High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.
Journal
Turkish thoracic journal
ISSN: 2149-2530
Titre abrégé: Turk Thorac J
Pays: Turkey
ID NLM: 101648545
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
4
2
2022
Statut:
ppublish
Résumé
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.
Identifiants
pubmed: 35110267
doi: 10.5152/TurkThoracJ.2021.20213
pmc: PMC8975303
doi:
Types de publication
Journal Article
Langues
eng
Pagination
494-500Références
Respir Care. 2015 Feb;60(2):162-9
pubmed: 25371400
Respir Care. 2016 Mar;61(3):291-9
pubmed: 26577199
Respir Care. 2013 Apr;58(4):597-600
pubmed: 22781059
Respir Care. 2011 Mar;56(3):265-70
pubmed: 21255498
Intern Med. 2015;54(18):2307-13
pubmed: 26370853
Respir Care. 2019 Jun;64(6):735-742
pubmed: 31110041
J Crit Care. 2012 Jun;27(3):324.e9-13
pubmed: 21958974
J Crit Care. 2012 Oct;27(5):434-9
pubmed: 22762937
Crit Care. 2015 Nov 02;19:380
pubmed: 26521922
Eur Respir Rev. 2017 Aug 9;26(145):
pubmed: 28794144
Acta Anaesthesiol Belg. 2016;67(2):63-72
pubmed: 29444391
Cureus. 2018 Nov 26;10(11):e3639
pubmed: 30740281
Ann Intensive Care. 2016 Dec;6(1):45
pubmed: 27207177
Iran J Allergy Asthma Immunol. 2019 Oct 16;18(6):615-623
pubmed: 32245305
Respir Care. 2010 Apr;55(4):408-13
pubmed: 20406507
Intensive Care Med. 2017 Oct;43(10):1453-1463
pubmed: 28762180
Respir Care. 2014 Apr;59(4):485-90
pubmed: 24046462
Respir Care. 2012 Nov;57(11):1873-8
pubmed: 22417844
Crit Care. 2016 Apr 28;20(1):109
pubmed: 27121707
Respir Care. 2015 Oct;60(10):1390-6
pubmed: 26106206
Transplantation. 2015 May;99(5):1092-8
pubmed: 25340596
J Intensive Care. 2015 Mar 31;3(1):15
pubmed: 25866645
BMC Anesthesiol. 2014 Aug 07;14:66
pubmed: 25110463
Intensive Care Med. 2017 Mar;43(3):465-467
pubmed: 27904928
Intensive Care Med. 2011 Nov;37(11):1780-6
pubmed: 21946925
Respir Care. 2015 Feb;60(2):170-8
pubmed: 25294935
N Engl J Med. 2015 Jun 4;372(23):2185-96
pubmed: 25981908
Crit Care. 2018 May 9;22(1):120
pubmed: 29743098
Respir Care. 2017 Jul;62(7):888-895
pubmed: 28442633